ARCHIVES

FDA Spells Out Requirement For INDs For Cancer Drugs.

This article is from The Cancer Letter archive.

Vol. 28 No. 20 | May 17, 2002

Download PDF Visit The Full Archive

Related Articles

FDA Delays NDA On BCNU, But New Drug Seminar Still Scheduled

November 28, 1975

Wall Street Analyst Who Sounded Alarm Over Prostate Cancer Drug Provenge In JNCI Settles With SEC Over Shorting Dendreon Stock

December 17, 2013

Other DCT Concepts Approved By BSC

June 6, 1986

In Brief: Golomb, Weinstein Head ASCO, AACR; Abeloff, Moses Presidents Elect; Sackett Heads AUR

June 1, 1990

Interest Picks Up In SBIR, NCI May Not Gave To Face Choice of Giving Money Back Or Paying to 500 Level

November 23, 1984

Kramer Says New Radiotherapy Could Save 1.3 Of Failures

February 18, 1977